The Pfizer Board: Science and Technology Committee
The Science and Technology Committee was established in 2003. Under the terms of its Charter, the Committee is responsible for periodically examining management's direction and investment in the Company's pharmaceutical Research & Development as well as in its technology initiatives.
The Committee may meet privately with independent consultants and be free to speak directly and independently with any members of management in discharging its responsibilities.
| Board Member | Independent | Position |
|---|---|---|
| Dennis A. Ausiello | Yes | Member |
| Michael S. Brown | Yes | Chair |
| Robert N. Burt | Yes | Member |
| Frances D. Fergusson | Yes | Member |
| William H. Gray III | Yes | Member |
| James M. Kilts | Yes | Member |
| George A. Lorch | Yes | Member |
| John P. Mascotte | Yes | Member |
| Dana G. Mead | Yes | Member |
| Suzanne Nora Johnson | Yes | Member |
| William C. Steere, Jr.* | No | Member |
 |
If you do not have Adobe® Reader, download it here. It is available without charge from Adobe®. This link is provided as a convenience. Pfizer is not responsible for the content of this linked page. |
Learn more about our commitments and performance in the area of corporate responsibility.
Pfizer Annual Review:
Doing Things Differently
We are becoming the Pfizer we are meant to be — one that can offer healthy solutions at every stage of life.
- Contact Us
- Investors
- Sitemap
- Careers
- Business to Business
- Terms of Use
- Global Network
- Privacy Policy
Copyright © 2002–2009 Pfizer Inc. All rights reserved. This information is intended only for residents of the United States. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. Pfizer Inc is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
